secwatch.observer — SEC 8-K summary
======================================

Issuer:     STANDARD BIOTOOLS INC. (LAB)
CIK:        0001162194
Form:       8-K
Filed at:   2026-06-18T20:30:17+00:00
Accession:  0001193125-26-275946
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve 2026 Equity Incentive Plan and ESPP amendment increasing share reserve by 1.2M
--------------------------------------------------------------------------------

- Three Class I directors elected: Michael Egholm (236.3M for), Thomas Carey (227.8M for), Eli Casdin (234.7M for).
- Advisory vote on executive compensation approved: 209.8M for, 36.3M against.
- Ratification of PwC as independent auditor approved: 330.2M for, 0.7M against.
- 2026 Equity Incentive Plan approved: 228.3M for, 17.8M against.
- ESPP amendment to increase share reserve by 1.2M shares approved: 237.5M for, 12.3M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1162194/000119312526275946/0001193125-26-275946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1162194/000119312526275946/lab-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-275946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer